Avrobio's road ends in reverse merger with Tim Springer-backed startup
BioPharma
Stay updated with breaking news from Erik Ostrowski. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Combined company to be Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing Tectonic’s novel GPCR-targeted therapeutic proteins $130.7 million in private financing...
TURKU, Finland and BOSTON, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Faron Pharmaceuticals Ltd (AIM: FARN, First North: FARON), a clinical-stage biopha...
TURKU, Finland and BOSTON, Sept. 22, 2023 -- Faron Pharmaceuticals Ltd , a clinical-stage biopharmaceutical company focused on tackling cancers via novel immunotherapies, announces that the...
The gene therapy developer, which recently sold its cystinosis program to Novartis, said it is considering M&A and other options.